Prior information notice
This notice is a call for competition
Section I: Contracting
authority
I.1) Name and addresses
Porton Biopharma
Salisbury
UK
E-mail: gary.topley@portonbiopharma.com
NUTS: UKK1
Internet address(es)
Main address: https://portonbiopharma.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://portonbiopharma.bravosolution.co.uk
Tenders or requests to participate must be sent to the following address:
https://portonbiopharma.bravosolution.co.uk
Salisbury
UK
E-mail: gary.topley@portonbiopharma.com
NUTS: UKK1
Internet address(es)
Main address: https://portonbiopharma.bravosolution.co.uk
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://portonbiopharma.bravosolution.co.uk
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
150083 PPC Zones 5-8 Reconfiguration Design Services
II.1.2) Main CPV code
71000000
II.1.3) Type of contract
Services
II.1.4) Short description
Reconfiguration of a pharmaceutical manufacturing facility.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
71200000
71210000
71220000
71221000
71223000
71250000
71320000
71321000
II.2.3) Place of performance
NUTS code:
UKK1
II.2.4) Description of the procurement
Please note that this procurement is designated official sensitive and participation will only be allowed after agreeing to a confidentiality disclosure agreement.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
Please note that this procurement is designated official sensitive and participation will only be allowed after agreeing to a confidentiality disclosure agreement.
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Restricted procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of expressions of interest
Date:
22/07/2019
Local time: 17:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
Section VI: Complementary information
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4) Procedures for review
VI.4.1) Review body
Porton Biopharma Ltd
Salisbury
UK
VI.5) Date of dispatch of this notice
13/06/2019